Use of Noninvasive Nanotechnology to Image Alzheimer Disease in vivo in Beagles

Grants and Contracts Details

StatusFinished
Effective start/end date8/15/169/30/17

Funding

  • Alzeca Biosciences LLC: $114,931.00